Synthesis 2004(16): 2697-2703  
DOI: 10.1055/s-2004-831243
PAPER
© Georg Thieme Verlag Stuttgart · New York

Reactions of 1,4-Benzodiazepinic N-Nitrosoamidines with Tosylmethyl Isocyanide: A Novel Synthesis of Midazolam

Carlos del Pozo*, Alberto Macías, Eduardo Alonso, Javier González*
Departamento de Química Orgánica e Inorgánica, Universidad de Oviedo, Julián Clavería 8, 33071 Oviedo, Spain
e-Mail: fjgf@uniovi.es;
Weitere Informationen

Publikationsverlauf

Received 14 April 2004
Publikationsdatum:
22. September 2004 (online)

Abstract

Reaction of 1,4-benzodiazepinic N-nitrosoamidines, used as synthetic equivalents of imidoyl chlorides, with the mono-anion of tosylmethyl isocyanide is described. The process gives entry to 3-(4-tosyl)imidazo[1,5-a][1,4]benzodiazepines, compounds which have not been described yet in the literature. These systems can be derivatized to the corresponding trisubstituted 1,4-benzodiazepines by alkylation or acylation of the imidazole ring. These new heterocyclic derivatives are potentially useful in the field of medicinal chemistry. In addition, midazolam 3, the anesthetic properties of which are well established, can be easily prepared in one step by desulfonylation of compound 7a.

    References.

  • 40-1a Benzodiazepines Divided: A Multidisciplinary Review   Wiley; New York: 1983. 
  • 40-1b Bock MG. DiPardo RM. Evans BE. Rittle KE. Whitter WL. Veber DF. Anderson PS. Freidinger RM. J. Med. Chem.  1989,  32:  13 
  • 40-2 Sneader W. In Comprehensive Medicinal Chemistry   Vol. 1:  Hansch C. Sammes PG. Taylor JB. Pergamon; London: 1990.  p.65 
  • 40-3a Archer GA. Sternbach LH. Chem. Rev.  1968,  68:  747 
  • 40-3b Sharp JT. In Comprehensive Heterocyclic Chemistry II   Vol 7:  Katritzky AR. Rees CW. Pergamon; Amsterdam: 1984.  p.593 
  • 40-3c Tucker H. Le Count DJ. In Comprehensive Heterocyclic Chemistry II   Vol 9:  Katritzky AR. Rees CW. Scriven EFV. Elsevier; Amsterdam: 1996.  p.151 
  • For 1,4-benzodizazepines as inhibitors of reverse transcriptase, see:
  • 40-4a Robl JA. Cimarusti MP. Simpkins LM. Brown B. Ryono DE. Bird JE. Asaad MM. Schaeffer TR. Trippodo NC. J. Med. Chem.  1996,  39:  494 
  • 40-4b Merluzzi VJ. Hargrave KD. Labadia M. Grozinger K. Skoog M. Wu JC. Shih C.-K. Eckner K. Hattox S. Adams J. Rosenthal AS. Faanes R. Eckner RJ. Koup RA. Sullivan JL. Science  1990,  250:  1411 
  • For 1,4-benzodiazepines as antitumor and gene targeted drugs, see:
  • 40-5a Wang T. Lui AS. Cloudsdale IS. Org. Lett.  1999,  1:  1835 
  • 40-5b Novelli F. Sparatore A. Tasso B. Sparatore F. Bioorg. Med. Chem. Lett.  1999,  9:  3031 
  • 40-5c Wilson SC. Howard PW. Forrow SM. Hartley JA. Adams LJ. Jenkins TC. Kelland LR. Thurston DE. J. Med. Chem.  1999,  42:  4028 
  • 40-6 For 1,4-benzodiazepines as inhibitors of phosphodiesterases PDE4, see: Pascal Y. Andrianjara CR. Auclair E. Avenel N. Bertin B. Calvet A. Féru F. Lardon S. Moodley I. Ouagued M. Payne A. Pruniaux M.-P. Szilagyi C. Bioorg. Med. Chem. Lett.  2000,  10:  35 
  • For 1,4-benzodiazepines as potent and selective oxytocin antagonist, see:
  • 40-7a Evans B. Pipe A. Clark L. Banks M. Bioorg. Med. Chem. Lett.  2001,  11:  1297 
  • 40-7b Wyatt PG. Allen MJ. Chilcott J. Hickin G. Miller ND. Woollard PM. Bioorg. Med. Chem. Lett.  2001,  11:  1301 
  • For 1,4-benzodiazepines as antagonists of the GPllb/llla receptor, see:
  • 40-8a Hayes JF. Synlett  1999,  865 
  • 40-8b Andrews IP. Atkins RJ. Badham RF. Bellingham RK. Breen GF. Carey JS. Etridge SK. Hayes JF. Hussain N. Morgan DO. Share AC. Smith SAC. Walsgrove TC. Wells AS. Tetrahedron Lett.  2001,  42:  4915 
  • 40-9 For 1,4-benzodiazepines as cholecystokinin (CCK-A) receptor antagonists, see: Sherrill RG. Berman JM. Birkemo L. Croom DK. Dezube L. Ervin GN. Grizzle MK. James MK. Johnson MF. Queen KL. Rimele TJ. Vanmiddlesworth F. Sugg EE. Bioorg. Med. Chem. Lett.  2001,  11:  1145 
  • For 1,4-benzodiazepines as herbicides, see:
  • 40-10a Karp GM. Manfredi MC. Guaciaro MA. Ortlip CL. Marc P. Szamosi IT. J. Agric. Food Chem.  1997,  45:  493 
  • 40-10b Karp GM. J. Org. Chem.  1999,  64:  8156 
  • 40-11a Vida JA. In Medicinal Chemistry   Wolf MW. Burger A. Wiley; New York: 1981.  p.787 
  • 40-11b Fryer RI. In Comprehensive Heterocyclic Chemistry   Vol 3:  Hansch C. Pergamon Press; New York: 1990.  p.539 
  • 40-12a Hester JB. Rudzik AB. Kamdar BV. J. Med. Chem.  1971,  14:  1078 
  • 40-12b Schulte E. Dtsch. Apoth.-Ztg.  1975,  115:  1243 
  • 40-12c Gilman NW. Holland BC. Fryer RI. J. Heterocycl. Chem.  19 77,  14:  1163 
  • 40-12d Walser A. Benjamin LE. Flynn T. Mason C. Schwartz R. Fryer RI. J. Org. Chem.  1978,  43:  936 
  • 40-13a Hester JB. Duchamp D. Chidester CG. Tetrahedron Lett.  1971,  1609 
  • 40-13b Coffen DL. DeNoble JP. Evans EL. Field GF. Fryer RI. Katonak DA. Mandel BJ. Sternbach LH. Zally WJ. J. Org. Chem.  1974,  39:  167 
  • 40-13c Gall M. Hester JB. Rudzik AD. Lahti RA. J. Med. Chem.  1976,  19:  1057 
  • 40-13d Hester JB. J. Heterocycl. Chem.  1980,  17:  575 
  • 40-13e Hester JB. Rudzik AD. Voigtlander PFV. J. Med. Chem.  1980,  23:  392 
  • 40-13f Hester JB. Rudzik AD. Voigtlander PFV. J. Med. Chem.  1980,  23:  402 
  • 40-13g Hester HB. Rudzik AD. Voigtlander PFV. J. Med. Chem.  1980,  23:  643 
  • 40-13h Gall M. Kamdar BV. J. Med. Chem.  1981,  24:  1575 
  • 40-13i Walser A. Fryer RI. J. Heterocycl. Chem.  1983,  20:  551 
  • 40-13j Gall M. Kamdar BV. J. Heterocycl. Chem.  1988,  25:  1649 
  • 40-13k Banks WL. Digenis GA. Tetrahedron Lett.  1989,  6473 
  • 40-13l Hester JB. Ludens JH. Emmert DE. West BE. J. Med. Chem.  1989,  32:  1157 
  • 40-13m Walser A. Flynn T. Mason C. Crowley H. Maresca C. Yaremko B. O’Donnel M. J. Med. Chem.  1991,  34:  1209 
  • 40-14 Ning RY. Fryer RI. Madan PB. Sluboski BC. J. Org. Chem.  1976,  41:  2724 
  • 40-15 Walser A. Fryer RI. J. Org. Chem.  1975,  40:  153 
  • 40-16 van Leusen AM. Lect. Heterocycl. Chem.  1980,  5:  S-111  
  • 40-17a van Nispen SPJM. Mensink C. van Leusen AM. Tetrahedron Lett.  1980,  3723 
  • 40-176b Massa S. Di Santo R. Costi R. Mai A. Artico M. Med. Chem. Res.  1993,  3:  192 
  • 40-17c Di Santo R. Massa S. Artico M. Il Farmaco  1993,  48:  209 
  • 40-17d Sisko J.; J. Org. Chem.; 1998, 63: 4529
  • 40-17e Mendiola J. Minguez JM. Alvarez-Buylla J. Vaquero JJ. Org. Lett.  2000,  2:  3253 
  • 40-17f Sisko J. Kassick AJ. Mellinger M. Filan JJ. Allen A. Olsen MA. J. Org. Chem.  2000,  65:  1516 
  • 40-17g Chen P. Barrish JC. Iwanowicz E. Lin J. Bernarz MS. Chen B.-C. Tetrahedron Lett.  2001,  4293 
  • 40-17h Barret AGM. Cramp SM. Hennessy A. Procopiou PA. Roberts RS. Org. Lett.  2001,  3:  271 
  • 40-17i Kobayashi K. Matsumoto T. Irisawa S. Yoneda K. Morikawa O. Konishi H. Heterocycles  2001,  55:  973 
  • 40-17j Nair V. Vinod AU. Rajesh C. J. Org. Chem.  2001,  66:  4427 
  • 40-18 van Leusen AM. Wildeman J. Oldenziel OH. J. Org. Chem.  1977,  42:  1153 
  • 40-19a Walser A. Fryer RI. Sternbach LM. J. Heterocycl. Chem.  1974,  11:  619 
  • 40-19b Walser A. Benjamin L. Flynn T. Mason C. Schwartz R. Fryer R. J. Org. Chem.  1978,  43:  936 
  • 40-20 Bock MG. Di Pardo RM. Evans BE. Rittle KE. Veber DF. Freidinger RM. Hirshfield J. Springer JP. J. Org. Chem.  1987,  52:  3232 
  • 40-21 Bakhtiar C. Smith EH. J. Chem. Soc., Perkin Trans. 1  1994,  243 
  • 40-22 Nájera C. Yus M. Tetrahedron  1999,  55:  10547 
  • 40-23 Addie MS. Taylor RJV. J. Chem. Soc., Perkin Trans. 1  2000,  527 
  • 40-24a Holton RA. Crouse DJ. Williams AD. Kennedy RM. J. Org. Chem.  1987,  52:  2317 
  • 40-24b Adrio J. Rivero MR. Carretero JC. Angew. Chem. Int. Ed.  2000,  39:  2906 
  • 40-24c Adrio J. Rivero MR. Carretero JC. Chem.-Eur. J.  2001,  7:  2435 
40-25

For a slightly different reduction process using Zn-AcOH and leading to a similar product see earlier reference.13m